Yelomed Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 1 Year 3 Months
About Yelomed Pharmaceutical
Yelomed Pharmaceutical Private Limited (YPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 October 2023 (One year and three months 9 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Indira, Biswajit Chattopadhyay, Sunil Godara, and One other member serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U46497DL2023PTC422032
-
Company No.
422032
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Oct 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Yelomed Pharmaceutical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mangilal Vishnoi
|
Managing Director | 30-Oct-2023 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Indira
|
Director | 30-Oct-2023 | Current |
|
Biswajit Chattopadhyay
|
Whole-Time Director | 30-Oct-2023 | Current |
|
Sunil Godara
|
Whole-Time Director | 30-Oct-2023 | Current |
Financial Performance of Yelomed Pharmaceutical.
Enhance accessibility to Yelomed Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yelomed Pharmaceutical?
Unlock access to Yelomed Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Hospkart Healthique Private LimitedSunil Godara is a mutual person
-
Hotre Industries Private Limited
Mangilal Vishnoi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Yelomed Pharmaceutical?
Unlock and access historical data on people associated with Yelomed Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yelomed Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yelomed Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.